Drug Channels

MARCH 4, 2025

2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Emerging controversies, challenges, and threats to watch in the industry And much more! DCI reserves the right to prohibit purchasers who violate our terms from attending future DCI webinars. Unfortunately, we are unable to offer refunds.

Specialty Pharmacies 94

Specialty Pharmacies Drug Pricing Labelling 94

Drug Channels

OCTOBER 3, 2023

CVS Health launched Cordavis, a new subsidiary that will market a private label, low-list-price version of Sandoz’ Hyrimoz. Surprisingly, two PBMs—Express Scripts and OptumRx—will each offer at least one low-list-price biosimilar option on their main national formularies. d/b/a Drug Channels Institute.

Biosimilars 98

Biosimilars Drug Pricing Labelling 98

Drug Channels

NOVEMBER 12, 2024

Read on for full details on pricing and registration. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Fein will clearly distinguish his opinions and interpretations from the objective facts and data. He will draw from exclusive information found in DCI's economic reports.

Drug Pricing 98

Drug Pricing Biosimilars Labelling 98